SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024653
Filing Date
2020-05-12
Accepted
2020-05-12 16:06:40
Documents
57
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idya-10q_20200331.htm 10-Q 2067822
2 EX-10.2 idya-ex102_336.htm EX-10.2 103692
3 EX-10.3 idya-ex103_337.htm EX-10.3 61793
4 EX-10.4 idya-ex104_335.htm EX-10.4 288915
5 EX-31.1 idya-ex311_8.htm EX-31.1 18183
6 EX-31.2 idya-ex312_9.htm EX-31.2 18214
7 EX-32.1 idya-ex321_7.htm EX-32.1 12375
  Complete submission text file 0001564590-20-024653.txt   6238215

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT idya-20200331.xml EX-101.INS 1073883
9 XBRL TAXONOMY EXTENSION SCHEMA idya-20200331.xsd EX-101.SCH 40246
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idya-20200331_cal.xml EX-101.CAL 38477
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idya-20200331_def.xml EX-101.DEF 125805
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20200331_lab.xml EX-101.LAB 337343
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20200331_pre.xml EX-101.PRE 248738
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 20869119
SIC: 2834 Pharmaceutical Preparations